eli lilly cease and desist letter tirzepatide Novo sues Lilly, claiming misleading ads in weight-loss drug battle Tirzepatide gives Novo Nordisk's semaglutide

The weekly check-in care structure means patients have more frequent provider contact than typical telehealth weight loss programs, which may involve only monthly consultations or automated refill systems

[DOI] [PubMed] [Google Scholar] Ji Q

FDA banned it in late 2023 "Category 2: Substance with Safety Concerns" Why the FDA banned it: Potential immune reactions (immunogenicity) Manufacturing impurities in compounded versions Complete lack of human safety data Risk of contamination Legal status: NOT FDA-approved Illegal to compound in pharmacies Banned by WADA for athletes Possession not illegal (it's not a DEA scheduled substance) Sold online as "research chemical" 2

A registered dietitian can provide personalised guidance

10.1016/j.dld.2015.07.150 209